Controlled release neurotoxin system
US6585993B2 · kind B2 · utility
65Cited by
21References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2002 |
| Grant date | Jul 1, 2003 |
| Priority date | — |
| Expiry date | Mar 11, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A biocompatible implant for continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years. The implant can be made of casting a solution of a polymer, such as an ethyl vinyl acetate copolymer and the neurotoxin. The neurotoxin can be a botulinum toxin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.